Clinical Trials in Tennessee

Showing 4721-4740 of 20,239 trials

A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream

NCT06213831

This study is being conducted to determine the safety and tolerability of ruxolitinib 1.5% cream under maximal use conditions in participants with Prurigo Nodularis (PN).

Prurigo Nodularis

Incyte Corporation23 participantsStarted Feb 2024

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • Fountain Valley, California, United States +17 more locations

RECRUITINGNA29 miles

Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]

NCT06125743

The goal of this study is to evaluate the effectiveness of a standardized lymphedema and fibrosis self-management program (LEF-SMP) to improve LEF self-management and reduce LEF-associated symptom burden, functional deficits, and improve quality of life in head and neck cancer (HNC) survivors.

Lymphedema of the Head and Neck

Abramson Cancer Center at Penn Medicine204 participantsStarted Mar 2024

Philadelphia, Pennsylvania, United States • Nashville, Tennessee, United States

A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream

Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]

Find Trials by Condition in Tennessee

The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study

A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

Executive Function in Early Childhood

CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer

Expanded Access of Sotorasib

Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis

Evaluation of Accuracy of the Owlet OSS 3.0 Sensor in the Neonatal Population

Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)

A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

Nonalcoholic Fatty Liver Disease (NAFLD) Database 3

Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)

A Study to Test Whether Different Doses of BI 1291583 Help People With Bronchiectasis

Air Optix Plus HydraGlyde Multifocal Daily/Extended Wear Contact Lenses

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia

A Real-World Evidence (RWE) Long-Term Follow-Up Study to Assess Outcomes of Alcon Monofocal Intraocular Lenses

Topical ENS-002 for Atopic Dermatitis in Adults